Currently holds a position at Pliant Therapeutics Inc
Position | Company | Period |
---|---|---|
Chief Business Officer | Pliant Therapeutics Inc | None - |
Senior Vice President - Business Operations | Adverum Biotechnologies Inc | Dec. 9, 2015 - Feb. 12, 2016 |
Interim President and Chief Executive Officer | Adverum Biotechnologies Inc | July 23, 2015 - Dec. 9, 2015 |
Senior Vice President - Legal and Corporate Development | Adverum Biotechnologies Inc | July 1, 2014 - July 23, 2015 |
Vice President of Legal and Corporate Development | Adverum Biotechnologies Inc | Jan. 1, 2011 - July 1, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-07 | 2023-08-04 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
20,050
-9.3%
20.01401,201 USD |
20,050 -9.3% | 20.01 | 401,201 USD | |
2023-08-07 | 2023-08-03 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
13,069
-6.0%
20.00261,380 USD |
13,069 -6.0% | 20.00 | 261,380 USD | |
2023-07-19 | 2023-07-17 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
17,937
-7.6%
18.01323,029 USD |
17,937 -7.6% | 18.01 | 323,029 USD | |
2023-04-03 | 2023-03-30 |
Pliant Therapeutics Inc
(PLRX)
|
PS Planned sale |
9,036
-4.3%
26.52239,643 USD |
9,036 -4.3% | 26.52 | 239,643 USD | |
2022-12-21 | 2022-12-20 |
Pliant Therapeutics Inc
(PLRX)
|
S Sale |
8,748
-6.0%
19.10167,108 USD |
8,748 -6.0% | 19.10 | 167,108 USD |